Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.

Kudahetti, SC; Fisher, G; Ambroisine, L; Prowse, D; Kattan, MW; Foster, CS; Møller, H; Oliver, T; Fletcher, A; Cooper, C; +5 more... Reuter, V; Scardino, P; Cuzick, J; Berney, DM; Transatlantic Prostate Group; (2010) Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. Pathology, 42 (6). pp. 519-23. ISSN 0031-3025 DOI: https://doi.org/10.3109/00313025.2010.508788

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3109/00313025.2010.508788

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar